NEOSOLDEX Trademark

Trademark Overview

On Tuesday, February 28, 2017, a trademark application was filed for NEOSOLDEX with the United States Patent and Trademark Office. The USPTO has given the NEOSOLDEX trademark a serial number of 79206963. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 2, 2018. This trademark is owned by LABORATOIRES C.T.R.S.. The NEOSOLDEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products; medicines for human medicine; chemical preparations for medical use; chemical preparations for pharmaceutical use
neosoldex

General Information

Serial Number79206963
Word MarkNEOSOLDEX
Filing DateTuesday, February 28, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 2, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical products; medicines for human medicine; chemical preparations for medical use; chemical preparations for pharmaceutical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 12, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRES C.T.R.S.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Thursday, May 7, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 15, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 17, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 2, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 2, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, November 2, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 17, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 17, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, January 2, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 2, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 2, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, June 17, 2017REFUSAL PROCESSED BY IB
Friday, May 26, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 26, 2017REFUSAL PROCESSED BY MPU
Thursday, May 25, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 24, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 23, 2017ASSIGNED TO EXAMINER
Tuesday, May 16, 2017APPLICATION FILING RECEIPT MAILED
Friday, May 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 11, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

neosoldex preparations chemical pharmaceutical medical human products medicines medicine